Pyelonephritis Pipeline Review, H2 Global Share and Size, Trends and Growth, Segment Forecast to 2015

1. Hexa Reports Market Research Reports and Insightful Company Profiles Pyelonephritis Industry 2015 Market Share, Size, Industry Profile, Market Prize, Forecast and Overview Global Markets Direct's, 'Pyelonephritis - Pipeline Review, H2 2015', provides an overview of the Pyelonephritis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pyelonephritis and special features on late-stage and discontinued projects. Browse Detail Report With TOC @ http://www.hexareports.com/report/pyelonephritis-pipeline- review-h2-2015/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

2. Hexa Reports Market Research Reports and Insightful Company Profiles The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global therapeutic landscape of Primary Pyelonephritis The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Primary Pyelonephritisand enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Primary Pyelonephritisproducts under development by companies and universities/research institutes based on information derived from company and industry specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Primary Pyelonephritispipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Primary Pyelonephritis Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Primary Pyelonephritispipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

3. Hexa Reports Market Research Reports and Insightful Company Profiles Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ http://www.hexareports.com/sample/46620 Table Of Content Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Pyelonephritis Overview 6 Therapeutics Development 7 Pipeline Products for Pyelonephritis - Overview 7 Pipeline Products for Pyelonephritis - Comparative Analysis 8 Pyelonephritis - Therapeutics under Development by Companies 9 Pyelonephritis - Pipeline Products Glance 10 Late Stage Products 10 Clinical Stage Products 11 Pyelonephritis - Products under Development by Companies 12 Pyelonephritis - Companies Involved in Therapeutics Development 13 Achaogen Inc. 13 AstraZeneca Plc 14 Merck & Co., Inc. 15 MerLion Pharmaceuticals Pte Ltd 16 The Medicines Company 17 Pyelonephritis - Therapeutics Assessment 18 Assessment by Monotherapy Products 18 Assessment by Combination Products 19 Assessment by Target 20 Assessment by Mechanism of Action 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 27 (ceftazidime + avibactam sodium) - Drug Profile 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 (meropenem+ RPX-7009) - Drug Profile 29 Product Description 29 Mechanism of Action 29

4. Hexa Reports Market Research Reports and Insightful Company Profiles R&D Progress 29 finafloxacin - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 plazomicin sulfate - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 relebactam - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Pyelonephritis - Recent Pipeline Updates 37 Pyelonephritis - Dormant Projects 43 Pyelonephritis - Discontinued Products 44 Pyelonephritis - Product Development Milestones 45 Featured News & Press Releases 45 Browse Full Report @http://www.hexareports.com/report/pyelonephritis-pipeline-review-h2- 2015/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/